| SLC13A5 Deficiency Natural History Study - United States Only (NCT06144957) | TESS Research Foundation | 2021-12-01 |
| SLC13A5 Deficiency Natural History Study - Remote Only (NCT04681781) | TESS Research Foundation | 2021-03-01 |
| DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study (NCT05212428) | Mayo Clinic | 2020-01-22 |
| Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome) (NCT03435627) | Novo Nordisk A/S | 2018-02-26 |
| Delineation of Novel Monogenic Disorders in the United Arab Emirates Population (NCT03589079) | Imperial College London Diabetes Centre | 2018-01-01 |
| Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART (NCT06898307) | University Hospital of Ferrara | 2017-11-01 |
| Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis (NCT03093220) | Peking University People's Hospital | 2017-03-01 |
| Pediatric Patients With Metabolic or Other Genetic Disorders (NCT02769949) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2016-05-03 |
| Lipid Transport Disorder Italian Genetic Record (LIPIGEN) (NCT06362473) | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 2015-08-04 |
| Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage (NCT03065114) | Yeh | 2014-12-01 |
| Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy (NCT01851447) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-11-03 |
| Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome (NCT01927861) | Novo Nordisk A/S | 2013-08-19 |
| A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin (NCT01435629) | Novo Nordisk A/S | 2012-11-22 |
| Inherited Reproductive Disorders (NCT01500447) | National Institute of Environmental Health Sciences (NIEHS) | 2012-04-25 |
| Brain-Derived Neurotrophic Factor in Obesity and Brain Function (NCT01517048) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2012-01-09 |
| Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers (NCT01401244) | Novo Nordisk A/S | 2011-07-14 |
| Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone (NCT01327924) | Novo Nordisk A/S | 2011-04-01 |
| Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents (NCT01245374) | Novo Nordisk A/S | 2010-11-01 |
| Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants (NCT01135537) | The Hospital for Sick Children | 2009-11-01 |
| Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome (NCT00705172) | Novo Nordisk A/S | 2008-11-01 |
| Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders (NCT00358657) | Fred Hutchinson Cancer Center | 2006-05-24 |
| Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128) | Novo Nordisk A/S | 2006-04-01 |
| Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (NCT01604161) | Novo Nordisk A/S | 2005-05-01 |
| Studies of Children With Metabolic and Other Genetic Disorders (NCT00025870) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2001-10-25 |
| Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867) | Novo Nordisk A/S | 2001-01-01 |
| Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT01563926) | Novo Nordisk A/S | 2000-10-23 |
| Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome (NCT01710696) | Novo Nordisk A/S | 1998-07-23 |
| Special Survey for Long Term Application (NCT01516229) | Novo Nordisk A/S | 1997-05-01 |
| Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome (NCT01529840) | Novo Nordisk A/S | 1990-06-01 |
| Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome (NCT01518062) | Novo Nordisk A/S | 1989-11-01 |
| Use of Somatropin in Turner Syndrome (NCT01518036) | Novo Nordisk A/S | 1987-09-14 |